Concert Pharmaceuticals, Inc.
DEUTERATED DERIVATIVES OF RUXOLITINIB
Last updated:
Abstract:
The present invention in one embodiment provides a compound of Formula A: ##STR00001## or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising the compound; and methods of treating the indications disclosed herein.
Status:
Application
Type:
Utility
Filling date:
10 Dec 2020
Issue date:
28 Oct 2021